Application Nr Approved Date Route Status External Links
ANDA203232 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage Tenofovir Disoproxil Fumarate Tablets Are A Nucleotide Analog Hiv-1 Reverse Transcriptase Inhibitor And An Hbv Reverse Transcriptase Inhibitor And Is Indicated: • In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients 2 Years Of Age And Older Weighing At Least 10 Kg. ( 1.1 ) • For The Treatment Of Chronic Hepatitis B In Adults And Pediatric Patients 12 Years And Older. ( 1.2 ) 1.1 Hiv-1 Infection Tenofovir Disoproxil Fumarate Tablets Are Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adults And Pediatric Patients 2 Years Of Age And Older Weighing At Least 10 Kg. 1.2 Chronic Hepatitis B Tenofovir Disoproxil Fumarate Tablets Are Indicated For The Treatment Of Chronic Hepatitis B Virus (Hbv) In Adults And Pediatric Patients 12 Years Of Age And Older. Pediatric Use Information Is Approved For Gilead Sciences, Inc.’s Viread® (Tenofovir Disoproxil Fumarate) Tablets. However, Due To Gilead Sciences, Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tenofovir Disoproxil Fumarate

Comments